1. Introduction {#s0005}
===============

Ambient temperature increase is an important public health concern, associated with substantial death and illness ([@bb0020]). Globally, the average temperature increased by 0.85 °C between 1880 and 2012 ([@bb9000]). Across most land areas, projections indicate an increase in the magnitude and frequency of hot days in the late 21st century ([@bb9000]). Furthermore, across many regions, low temperatures also contribute greatly to the current burden from total mortality ([@bb0045]). Understanding the health risks associated with high and low temperatures on elderly people is vital for preventing heat and cold-related deaths and illnesses in this vulnerable population ([@bb0030]). Elderly vulnerability is attributable to physiological and social factors, including; living alone, multiple co-morbidities and high medication use, slow physiological adaptation and behavioural response to thermal stress, limited access to medical care and housing with heating or cooling.

Forecasts predict an unprecedented rate of population ageing driven by lengthening life expectancy, particularly in urban areas. The 60 + age group is expected to comprise 21.1% of the population by 2050 ([@bb9005]). As people live longer, the global burden of chronic and degenerative disease will increase. The predominant contributors to the global burden of disease in the elderly are cardiovascular disease, malignant neoplasms, chronic respiratory diseases, musculoskeletal diseases and neurological and mental diseases ([@bb0110]).

Two recent reviews describe temperature effects on elderly people\'s health. A meta-analysis by Yu et al. report greater elderly risk (65 +) for all-cause heat-related mortality (2--5% per 1 °C increase in temperature) compared to all-cause cold-induced mortality in the 50 + age group (1--2% per 1 °C decrease in temperature) ([@bb0130]). The review of Astrom and colleagues asserts elderly people (65 +) are at greater risk of mortality and morbidity during exposure to heat waves than younger people ([@bb0015]). Because heat and cold waves only contribute to a small proportion of excess deaths ([@bb0045]), we focused on the association between exposure to non-optimum high and low temperatures rather than anomalous temperature events on health. Previous reviews have excluded critical epidemiological studies with information on the underlying cause of death. Cause-specific health impacts of temperature on the elderly have been reported sporadically, but coherent effort to integrate these has so far been lacking. Here we present a systematic review and meta-analysis with quantitative evidence on the effects of high and low ambient temperature (excluding heat and cold waves) on many cause-specific mortality and morbidity outcomes in the elderly.

2. Methods {#s0010}
==========

2.1. Inclusion Criteria {#s0015}
-----------------------

Epidemiological studies reporting an age-stratified, quantitative association between temperature and only cause-specific, elderly mortality or morbidity (hospitalisation, emergency room admissions, general practise visits, home visits) outcomes were considered. Time-series and case-crossover design studies were included because they produce comparable effect estimates ([@bb0030]) for investigating temperature and mortality/morbidity associations. Only English language publications were considered.

Temperature was the primary weather exposure. Indexes combining variables including temperature, humidity and wind velocity were considered, providing comparable risk estimates were produced. Other primary environmental exposures such as air pollution (including dust) were deemed outside the scope of this review. Heat studies were defined as those presenting effect estimates per unit increase above summer or yearly threshold temperatures, or linear effects with no threshold. Cold studies were those with effect estimates per unit below a winter or yearly threshold temperature, or no threshold for linear effects. Studies presenting non-linear risk estimates \[study ID 36\] not convertible to a 1 °C change in temperature were considered in the systematic review, but excluded from the meta-analysis, including effect estimates given as a comparison between two threshold temperatures \[study ID 56--61\] (study IDs are defined in [Table 1](#t0005){ref-type="table"}). Heat wave and cold waves were excluded because they are unique events with differing characteristics. To produce robust causal associations explaining the mechanisms linking exposure and outcome, studies were required to have analysed a minimum of three consecutive years/seasons of temperature-health associations. Studies investigating the effects of medication or binary exposures such as disasters were excluded.

A consistent definition of the elderly is yet to be applied in academic and policy discourse. Most definitions correspond with a retirement age of 65. Following this convention, we define elderly as those aged 65 + years with two caveats: to minimise information loss, studies combining the 65 + age group with slightly younger age groups (50--74, 56 +, 55--69 years) and studies in low-income countries with low life expectancy where the elderly were defined as 50 + were considered in this review.

2.2. Search Strategy {#s0020}
--------------------

Two investigators (AB and AV) conducted independent searches using Medical Subject Headings on the PubMed, Web of Science and Ovid Medline databases ([Supplementary File S1](#ec0005){ref-type="supplementary-material"}). English language studies published between 1 January 1975 and 24 July 2015 in peer-reviewed journals, on the effect of temperature exposure on cause-specific mortality or morbidity in the elderly were retrieved. Titles and abstracts were scanned for fit against the inclusion and exclusion criteria. Full text documents of candidate studies were integrated into one library and details corresponding to each publication recorded systematically. The results from both reviewers were compared and disagreements resolved by consulting two senior investigators (SH and NH). A consensus was reached on papers included in the review. Authors were contacted to obtain missing information required for this analysis.

2.3. Data Management and Statistical Analysis {#s0025}
---------------------------------------------

Cause-specific risk estimates were standardised to percent change (%) per 1 °C change in temperature. The most statistically significant effect estimate (and when unavailable, the highest effect estimate) was selected when results were presented for multiple lag days or thresholds. Unique datasets were created for each cause-specific mortality or morbidity disease outcome for heat and cold exposure. The percent change and 95% confidence interval was transformed into a beta coefficient (β) and standard error. A random-effects meta-analysis, which accounts for intra- and inter-city heterogeneity, was conducted. The two-staged analysis included; *i*) pooling of age-stratified risks (i.e. 65--74, 75 +) in individual studies to produce one estimate (65 +), *ii*) meta-analysis of city-specific estimates, requiring at least two effect estimates per disease category (indicated here as k \> 2).

Heterogeneity was investigated using the *I^2^* statistic, where increasing values (ranging 0--100%) correspond to increasing heterogeneity. Subgroup analysis was performed to test if *i*) the risk of mortality or morbidity increased with age, and *ii*) pooling age-stratified effect estimates into one estimate (i.e. 65--74, 75--84, 85 + years into 65 + years) increased heterogeneity. Further sensitivity analyses explored changes in risk estimates and/or heterogeneity scores based on lag days between exposure and outcome, temperature variable, type of hospital admission, grouping cholesterol and blood pressure-related cardiovascular outcomes, and control for air pollution in studies of respiratory outcomes. Publication bias was also assessed. All analyses were carried out using the Meta package v. 4.3--2 in R.

3. Results {#s0030}
==========

The systematic search retrieved 4984 mortality papers and 3777 morbidity papers. Of the 25 mortality and 35 morbidity papers that fit the inclusion and exclusion criteria, 18 mortality and 31 morbidity publications were suitable for meta-analysis ([Fig. 1](#f0005){ref-type="fig"}). The characteristics of studies investigating the effects of high and low temperature on cause-specific mortality and morbidity in the elderly are summarised in [Table 1](#t0005){ref-type="table"} (see also [Supplementary File 2](#ec0010){ref-type="supplementary-material"}). The locations studied were dispersed across Europe, Asia, North and South America, but not Africa. We applied the Köppen--Geiger classification ([@bb0075]) to further investigate geographic spread by five climate zones; 'A-Equatorial', 'B-Arid', 'C-Temperate', 'D-Snow' and 'E-Polar' ([Fig. 2](#f0010){ref-type="fig"}). Two studies \[study IDs 2,39\] are located in equatorial areas and one \[study ID 1\] in the arid zone. Clustering in the snow and temperate zones reflect the uneven distribution of study locations. The duration of the time-series ranged from 3 to 26 years. Studies used various forms of ambient temperature as the exposure. Mean daily ambient temperature was the most common exposure (28 studies). Apparent temperature (also termed heat index), a combined metric of temperature and humidity used to gauge human discomfort, was also common. Diurnal temperature range (DTR) an exposure accounting for temperature variability; the difference between daily maximum and minimum temperatures, was applied by six studies \[study IDs 4,11,23,27,29,34\]. A detailed analysis of exposure measures and study design/statistical modelling are in [Supplementary file 3 (S3)](#ec0015){ref-type="supplementary-material"}, [Supplementary file 4 (S4)](#ec0020){ref-type="supplementary-material"}.

Cause-specific mortality and morbidity outcomes in the systematic review and meta-analysis are reported using the International Classification of Disease (ICD 10) nomenclature and hierarchy ([Supplementary File S5](#ec0025){ref-type="supplementary-material"}). A total of 13 publications were suitable for only the systematic review, including study IDs 56--61, which present risk estimates comparing two temperatures ([Supplementary Table 2](#ec0010){ref-type="supplementary-material"}). The risk of cardiovascular and cerebrovascular outcomes, including cerebral infarction, cerebral haemorrhage and ischemic heart disease increased with heat \[study IDs 56--61\] and cold exposure in most studies \[study IDs 56--61\]. Only Pan, et al. report a 0.73 lower odds of cerebral haemorrhage at 32 versus 28 °C. Respiratory deaths decreased by 2.5% with heat exposure in Chicago, USA at 29 versus 18 °C \[study ID 59\]. Cold exposure increased the risk of allergy \[study ID 61\] and respiratory mortality and morbidity \[study IDs 58,59,61\]. A non-linear relative risk of mental health emergency department visits ranging from 1.05 to 1.09 at 25 °C was observed across three regions of Quebec, Canada \[study ID 36\]. Studies applying DTR \[study IDs 4,11,23,27,29,34\], an exposure metric not comparable to temperature or apparent temperature was included only in the systematic review. Cardiovascular mortality and morbidity relative risk increased in all but the 75 +; 0.95 (95% CI 0.06--1.84) \[study ID 4\], and 65--74 group; 0.99 (0.99--1.0) \[study ID 27\] per 1 °C increase in DTR. Heart failure morbidity increased dramatically in Hong Kong, China \[study ID 29\]. Interestingly, the risk of respiratory morbidity (all respiratory, respiratory tract infection) increased with a 1 °C increase in DTR \[study IDs 23,27,34\], whereas mortality decreased ([@bb0030]). In Taiwan \[study ID 27\], the 75 + group exhibited slightly elevated risks per 1 °C increase in DTR for renal; 1.02 (1.0--1.04) and digestive; 1.04 (1.02--1.05) morbidity compared with the 65 + age group.

We report mortality meta-estimates (where k \> 2) for ischemic heart disease (ICD-10 codes I20--25), all cardiovascular (I00--99), all cerebrovascular (I60--69), and all respiratory outcomes (J00--99). Morbidity meta-estimates (k \> 2) are presented for ischemic stroke (I63), intracerebral haemorrhage (I61), myocardial infarction (I21--23), angina pectoris (I20), heart failure (I50), asthma (J45--46), pneumonia (J09--18), diabetes mellitus (E10--14), acute renal failure (N17), intestinal infectious (A00--99), heat-related outcomes (E70--90, T66--78 and R00--99), all cardiovascular (I00--99), all cerebrovascular (I60--69), and all respiratory outcomes (J00--99). In addition, we present an 'overall' estimate for both mortality and morbidity outcomes, an amalgamation of the subgroups presented by individual studies including the 'all' category. The frequency count of each disease subgroup in the meta-analysis is given in [Fig. 3](#f0015){ref-type="fig"}. All cardiovascular disease (CVD) and all respiratory disease (RD) outweighed other mortality subgroups. A greater range of disease groups were represented by morbidity outcomes, including all RD and all CVD, followed by cerebral infarction, myocardial infarction, heart failure, all genitourinary disease, intestinal infection and diabetes mellitus. Threshold temperatures were selected by individual studies based on study location. Lag times, presented as cumulative or single day lags describing the delay between exposure and outcome, varied with high and low temperature. Heat lags were shorter than cold lags, generally between lag 0--1 to 0--3 days prior to the event. Cold lags ranged between 0 to 30 days.

We observed a striking increase in the risk of all mortality outcomes, including cerebrovascular, cardiovascular and respiratory outcomes ([Table 2](#t0010){ref-type="table"} and forest plots in [Supplementary File 6](#ec0030){ref-type="supplementary-material"}). The greatest risks were for heat-induced CVD and RD, and cold-induced RD mortality. Cerebrovascular (CBD) risks also increased with cold exposure. No protective effect (risk reduction) was found for any mortality outcome; only ischemic heart disease risk was statistically insignificant; 0.45% (95% CI − 0.01--0.91) per 1 °C decrease in temperature. Compared to the universally elevated mortality risks, temperature-related morbidity risks were mixed for CBD and CVD outcomes ([Table 3](#t0015){ref-type="table"} and forest plots in [Supplementary File 6](#ec0030){ref-type="supplementary-material"}). In warm periods, the risk of intracerebral haemorrhage, myocardial infarction and all CBD morbidity reduced per 1 °C increase in temperature. In winter, the risk of morbidity from angina, heart failure, all CVD, and all CBD reduced per 1 °C decrease in temperature. Heat exposure led to an increase in RD morbidity by 2.76% (1.51--4.03). A statistically significant increase was noted for heat-induced diabetes mellitus 1.02% (0.43--1.62) and an even greater risk for heat-related overall genitourinary morbidity 2.12% (1.65--2.59). A 1 °C increase in temperature resulted in elevated risks for overall infectious and heat-related morbidity. The greatest statistically significant risk was associated with pneumonia; 1 °C reduction in temperature caused a 6.89% (1.20--12.99) increase in morbidity in cold periods.

We explored temporal patterns of the temperature-outcome relationship (lags) for all diseases ([Supplementary File 7](#ec0035){ref-type="supplementary-material"}). We pooled heat effects as *a*) lag 0, 1 and 0--1, and *b*) above lag 2, and cold effects as *a*) \< lag 15 *b*) \> lag 15. The risk for heat-related CVD mortality was greatest for lag 0--1; 4.15% (3.7--4.59) relative to \> lag 2 days; 2.97% (1.8--4.15). The converse was observed for heat-related CVD morbidity; a longer lag was associated with a higher risk of illness 0.27% (0.03--0.51). The risk of both heat-induced respiratory mortality (5.33%, 3.69--6.99) and morbidity (2.76%, 1.32--4.21) were greater for lag \> 2 days. Heat-induced cerebrovascular mortality and morbidity risk estimates were elevated for the shorter lag, 0--1 days. The risks for heat-related diabetes, infectious, and renal disease morbidity were greater for the longer lag period of above 2 days. With the exception of cold-induced respiratory morbidity 6.98% (2.47--11.68, lag \< 15 days), low temperatures were associated with a greater risk of mortality and morbidity for the longer lag period of above 15 days for cardiovascular and respiratory outcomes.

Publication bias was assessed with funnel plots. The asymmetrical distribution of study results suggests some level of publication bias in plots B, C, E, N, P ([Supplementary File 8](#ec0040){ref-type="supplementary-material"}). These plots are characterised by few studies in the white triangle, showing that smaller, statistically insignificant results are missing. The apex of plots B, C, E, N, P are, however, dominated by studies with large sample sizes and low standard error, which can skew the plot to indicate publication bias.

Heterogeneity (*I*^*2*^) was high, between 60.8 to 99.2% for mortality causes and varied from 0 to 98.6% for morbidity outcomes, supporting our use of a random-effects meta-analysis. Through an age-specific analysis, we investigated if the high heterogeneity scores were attributable to grouping risk estimates from multiple age groups. Although *I*^*2*^ reduced drastically in the younger age group (65--74), heterogeneity remained high for the 75 + age group (between 59.3--94.9%) ([Supplementary File 9](#ec0045){ref-type="supplementary-material"}). Regression model choice appeared to be an important determinant of heterogeneity. Pooling independent studies resulted in larger *I*^*2*^ scores than pooling one study applying a consistent modelling strategy across multiple sites. Risks did not universally increase with age, as the 65--74 age group exhibited greater heat-induced all RD morbidity, all CBD mortality and cold-induced all RD mortality compared to the 75 + age group. We independently grouped heat-induced respiratory hospital admissions and emergency admissions to assess if pooling these outcomes was a cause of heterogeneity. The results were mixed; neither the relative risk nor *I*^*2*^ varied greatly for overall RD, although *I*^*2*^ for all RD hospital admissions dropped to 50.7% across 15 city-specific hospital admissions \[study IDs 28, 37, 39, 44, 45\]. We tested if pooling cholesterol and blood pressure-related CVD outcomes altered the results. We removed the 'all CVD' estimates from the 'overall CVD' meta-estimate and grouped the remaining diseases as being related to cholesterol (1), systemic blood pressure (2), or both (3). Only heat-induced CVD mortality had more than two cholesterol and blood pressure outcomes, to enable a comparison. Heat-related mortality was higher for cholesterol 0.06% (− 0.35--0.47) than blood pressure − 0.87% (− 4.93--3.38). There was very little difference between heat-induced overall CVD mortality (0.15%, 0.05--0.35), and cholesterol CVD mortality 0.06% (− 0.35--0.47).

Compared with the original risk estimates, controlling for air pollution caused a decrease in the relative risk in two of the four outcomes; heat-induced respiratory mortality, and cold-induced respiratory morbidity. Most of these reductions in relative risk were small to moderate (less than 2% per 1 °C change in temperature). The statistical significance only changed for overall cold-induced morbidity, where controlling for air pollution reduced the relative risk to 0.83% (− 2.53--4.37) per 1 °C decrease in temperature from 4.93% (1.54--8.44) ([Supplementary File 10](#ec0050){ref-type="supplementary-material"}). There was no consistent trend across mortality/morbidity, heat/cold studies supporting unanimous elevated risks for either apparent temperature or air temperature as the preferred exposure ([Supplementary File 11](#ec0055){ref-type="supplementary-material"}).

4. Discussion {#s0035}
=============

Our systematic review and meta-analysis reveals temperature is associated with an increase in risk across every cause-specific mortality outcome and most morbidity outcomes in the elderly. The dataset comprises greater than 16 million elderly case events and is to our knowledge the largest analysis of temperature on cause-specific outcomes in a vulnerable group. Relevant publications were identified in a comprehensive search and effort was made to obtain pertinent data not included in the original publications to meta-analyse a robust sample of city-specific estimates. CBD, CVD and RD featured high sample size (n) and number of city-specific estimates (k). Endocrine, genitourinary, and infectious disease risks were elevated with heat exposure, but require further study to increase the statistical power of the estimates. Age-stratified data were combined to obtain one effect per study location using the inverse variance method. This enabled a fair comparison of effect estimates because the age groups were similar.

By excluding heat and cold wave studies, we show that temperature exposure in time-series spanning three or more years/seasons is associated with increased risk for many cause-specific health outcomes in the elderly. Adverse heat effects are concerning because an increase in mean worldwide temperatures from global warming is anticipated ([@bb9000]). Future studies might also consider using a time-series of 30 + years to build evidence on climate change-related temperature effects on cause-specific health outcomes in the elderly. Inter-study heterogeneity (*I*^*2*^) was generally high. Although *I*^*2*^ exceeding 75% typically indicates considerable heterogeneity, this threshold is likely more suited for controlled epidemiological study designs. Observational studies on the temperature-health relationship, however, do not follow stringent reporting guidelines. A previous meta-analysis of temperature effects on cardiorespiratory health also reports *I*^*2*^ scores ranging 89--99% ([@bb0120]). Heterogeneity can be attributed to several factors including differences in location, exposure variable, modelling, lag structures, threshold temperatures, adjustment for confounding variables, and grouping of different morbidity outcomes (hospital, emergency or general practitioner (GP) visits). It remains unclear, however, why *I*^*2*^ reduced for hospital admissions, but not emergency admissions in our sensitivity analysis. Furthermore, inherent differences among locations including population age structure, access to medical care, social services for the elderly, housing quality and prevalence of air conditioning and heating/insulation can also increase *I*^*2*^ ([@bb0020], [@bb0070], [@bb0100]). Most studies in our meta-analysis are located in the 'C' or temperate climate zone; geographic location is unlikely to be the primary cause of heterogeneity ([@bb0120]). Given the physiological limits to human adaptation and climate sensitivity of local resources (i.e. crops, fisheries), populations living in regions with more extreme climates such as Africa are likely to be highly sensitive to shifts in temperature. There is need for better understanding of how the health risks vary for such groups. It proved unfeasible to obtain the original and covariate datasets for the 49 studies included here to run standardised regressions or test all causes of heterogeneity through meta-regression. We reason the studies meta-analysed here are comparable and produce meaningful results.

Risks were greatest for respiratory mortality and morbidity, with both heat and cold exposure, and longer lag periods. Heat exposure could trigger the release of inflammatory factors, increase ventilation and exacerbate chronic obstructive pulmonary disease ([@bb0125], [@bb0085], [@bb0090], [@bb0095], [@bb0005]), which is highly prevalent in the elderly. Anderson and colleagues also suggest that a few minutes of inhaling hot air can trigger adverse airway responses in the elderly, increasing morbidity ([@bb0005]). Although indoor crowding and/or reduced ventilation during winter is thought to increase viral transmission ([@bb0055]), alternative biological mechanisms have been proposed. Inspiration of cold air can cause bronchoconstriction and airway congestion, triggering asthma ([@bb0050]), and increase susceptibility to infection by reducing mucosal clearing ([@bb0040]). We conclude that further research is required to establish aetiological mechanisms for how exposure to moderate cold and particularly heat cause adverse respiratory outcomes in the elderly. Sensitivity analysis revealed only a small to moderate (less than 2% per 1 °C change in temperature) difference in the relative risk for studies that controlled for air pollution, with the exception of cold-induced respiratory morbidity. Although controlling for air pollution is common in studies of temperature on health, evidence suggests it is indeed important to capture the entire causal effect, rendering adjustment for air pollution unnecessary in most circumstances ([@bb0035]).

CBD and CVD risks were markedly elevated, but only for mortality. Heat causes an increase in cardiac output, redistributes blood flow away from core organs, attenuates vasodilatation and sweat rate, and increases the potential for thrombosis ([@bb0065]). These responses are worsened by the limited thermoregulatory capacity and high cholesterol levels in the elderly ([@bb0065]), elevating cardiovascular strain and the likelihood of acute coronary events. Furthermore, systems in the body do not act in isolation; infection or inflammation of the respiratory system can spur growth of atherosclerotic plaques and promote hypercoagulation, promoting thrombotic events ([@bb0080]). Cold exposure can also increase blood pressure, blood viscosity, systemic inflammation and thrombosis ([@bb0060]). The observed excess risk of CBD/CVD mortality compared to CBD/CVD morbidity may be attributable to short lag times where death occurs rapidly before hospitalisation. The reported cause of death may therefore be inaccurate, overlooking underlying conditions. Only a single study \[study ID 14\] investigated the impact of pre-existing hypertension on RD in the elderly. Furthermore, death rarely goes unreported but morbidity not leading to hospitalisation or a GP visit is likely under-reported. To more broadly capture the effect of temperature on morbidity, community-based data, such as from general practise and home visits should also be used in addition to hospitalisation data. We identified only one study that used GP data \[study ID 54\]. With the exception of heat-induced CVD mortality, because only cholesterol-related subgroups existed, we could not determine whether blood pressure-related risk increased with cold exposure and cholesterol-related risk increased with heat exposure. Our pooling strategy (of combining the blood pressure and cholesterol diseases) was therefore justified, considering the negligible difference between heat-induced overall CVD and cholesterol-related risk.

Diabetes and genitourinary morbidity increased with heat and longer lag periods. Chronic diseases such as diabetes can trigger metabolic, cardiovascular, neurologic and behavioural dysfunctions that impair thermoregulatory responses during heat stress ([@bb0070]). Poor glucose control and neuropathy attenuate sweating responses in type 2 diabetics ([@bb0070]), which is a concern as obesity and diabetes rates are projected to increase. Similarly, during heat exposure the diversion of blood from the splanchnic and renal vasculature to the periphery can stress the renal system ([@bb0115]). In addition to traditional diseases (CBD, CVD, RD) this exposes a need to more rigorously understand how temperature affects under-represented diseases such as renal, endocrine and mental outcomes. Addressed in only two studies \[study IDs 6,36\], data for the temperature effects on elderly mental health are severely lacking, despite neurological and mental diseases contributing highly to their burden of disease ([@bb0110]). Moreover, the ability to sense environmental cues and take preventive action is compromised ([@bb0025]), further endangering elderly people with mental and neurological illnesses. Few studies investigated temperature impacts on infectious disease. This bias is likely the result of geographic clustering of studies in Europe and other affluent countries, where elderly people are likely to be affected by diseases associated with longer life expectancy. To effectively capture global exposure-response effects, age-specific analysis of temperature on cause-specific mortality or morbidity in populated equatorial and arid zones are required. We found that the risk of heat-related outcomes increase with heat exposure. Unfortunately, the lack of a systematic definition of heat and cold-related deaths or illnesses is likely to have led to severe under-reporting of these causes, which are often considered only when no other cause can be determined.

Some limitations must be noted. We were unable to extend our analysis to quantify the attributable burden of risk to high and low ambient temperature. Only English language publications were considered. We present all effect estimates as originally reported irrespective of the magnitude or direction of the risk. We took precautions to exclude heat and cold wave studies, where extreme temperature is likely to favour increased risk estimates. Regardless of these measures, we found evidence of positive publication bias.

We identify substantially elevated risks in the elderly for temperature-induced cerebrovascular, cardiovascular, and respiratory outcomes in particular. In addition, we find heat exposure-associated increases in diabetes, genitourinary, heat-related and infectious disease morbidity, all of which are anticipated to grow in importance with climate change and global ageing.

The following are the supplementary data related to this article.Supplementary file 1 (S1)Example of Pubmed a) mortality and b) morbidity MeSH terms used to execute the search. The same (or analogous terms) were applied in the Ovid MEDLINE and Web of Science databases.Supplementary file 2 (S2)Detailed study characteristics. Effect estimates are given for studies only included in the systematic review. The effect estimates of studies included in the meta-analysis can be found in [Supplementary file 6](#ec0030){ref-type="supplementary-material"} (forest plots).Supplementary file 3 (S3)Temperature exposure metrics applied in epidemiological studies, how they are measured and their application. Numbers in the column form of variable or indices correspond with unique ID for each study in the systematic review and meta-analysisSupplementary file 4 (S4)Summary of study design and statistical models applied in temperature-mortality/morbidity studies. Dotted lines indicate a subgroup.Supplementary file 5 (S5)Summary of ICD diseases, codes, and abbreviations for which risk estimates have been provided by mortality and morbidity studies included in this systematic review and meta-analysis.The ICD disease hierarchy consists of broad disease groups (in bold), and corresponding subgroups. The diseases reported by each author and study ID are marked with ✓. Red (heat) and blue (cold) correspond to the exposure. Meta-analysis was possible where two or more risk estimates were provided for each disease row.Supplementary file 6 (S6)Forest plots. Percent change, 95% confidence interval and inverse-variance weights for all cause-specific mortality and morbidity outcomes. Heat risk estimates correspond to a 1 °C increase in temperature. Cold risk estimates correspond to a 1 °C decrease in temperature.Supplementary file 7 (S7)Random-effects meta-analytic % change (and 95% confidence interval) for cardiovascular, respiratory, cerebrovascular, endocrine, heat-related causes, infectious disease and renal outcomes in the elderly per 1 °C change in temperature using varied lag structures (heat = lag 0,1,0--1 or \> lag 2, cold = \< lag 15 or \> lag 15). Heat outcomes correspond to per 1 °C increase in temperature, and cold outcomes correspond to per 1 °C decrease in temperature. k = number of city-specific relative risks combined to obtain meta-estimate, I^2^ = heterogeneity score.Supplementary file 8Funnel plots for all health outcomes.The funnel plots feature a dotted triangle with 95% confidence intervals, null and summary effect lines. Shading highlights regions in which studies would need to be to achieve certain p-values: light grey (p-value \< 0.01), dark grey (p-value 0.1), and white (p-value \> 0.1). The shading helps distinguish publication bias from other causes of funnel plot asymmetry. If studies are missing in an area of statistical non-significance (white area), the asymmetry is likely to be caused by publication bias, whereas if studies are missing in areas of high statistical significance indicated by the darker regions then publication bias is less likely to be the cause of bias.Supplementary file 9 (S9)Age-specific meta-estimates for the 65--74 and 75 + age groups.Meta-analytic % change (95% confidence interval) is presented corresponding to per 1 °C increase in temperature for mortality and morbidity heat studies, and per 1 °C decrease in temperature for mortality cold studies. \* = relative risk, statistically significant at the 5% level. k = number of relative risks combined to obtain meta-estimate, I^2^ = heterogeneity score, p = p-value for the heterogeneity score, ![](fx1.gif) indicates an increase in risk, or ![](fx2.gif) indicates a risk reduction.Supplementary file 10 (S10)Random-effects meta-analytic % change (and 95% confidence interval) for respiratory outcomes in the elderly in studies that controlled for air pollution versus studies that did not control for air pollution. Heat outcomes correspond to per 1 °C increase in temperature, and cold outcomes correspond to per 1 °C decrease in temperature. k = number of city-specific relative risks combined to obtain meta-estimate, I^2^ = heterogeneity score. \* = statistically significant results.Supplementary file 11 (S11)Random-effects meta-analytic % change (and 95% confidence interval) for respiratory outcomes using different metrics of heat exposure (apparent temperature versus air temperature). Heat outcomes correspond to per 1 °C increase in temperature, and cold outcomes correspond to per 1 °C decrease in temperature. k = number of relative risks combined to obtain meta-estimate, I^2^ = heterogeneity score.
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![Distribution of A) Mortality, and B) Morbidity studies across five Köppen Geiger climate zones (A--E). Study numbers on the map (ID) are defined in [Table 1](#t0005){ref-type="table"}. Panel A comprises mortality studies (ID 1--20, 56--60), panel B comprises morbidity studies (ID 21--55, 61). ID 56--61 represent publications with risk estimates as a comparison between two temperatures. Repeated ID numbers on the map indicates that one study presents estimates for multiple cities.](gr2){#f0010}
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Descriptive study characteristics. Unique study ID corresponds to locations on [Fig. 2](#f0010){ref-type="fig"}. Exposure abbreviations: Temperature = T, Maximim = Max, Minimum = Min, Apparent Daily temperature = ADT, Mean Daily Temperature = MDT, Universal Thermal Climate Index (UTCI), Diurnal Temperature Range (DTR), PET index, (temperature, humidity, mean radiant temperature, wind speed). Additional information: RR = relative risk, CI = confidence interval, Threshold t = Threshold temperature, se = standard error. References to individual studies are listed in Supplementary file 2 (S2). Disease abbreviations: Subarachnoid haemorrhage (SAH), Intracerebral haemorrhage (IntH), Haemorrhagic stroke (HS), Cerebral infarction/Ischemic stroke (IS), Other CBD (other CBD), Stroke (unspecified as haemorrhage or infarction) (Stroke), Cerebrovascular disease (CBD), Essential hypertension (Hypertension), Ischemic heart disease (IHD), Angina (Angina), Myocardial infarction (MI), Aneurysm (Aneurysm), Pulmonary embolism (PulEmb), Heart failure (HF), Coronary atherosclerosis (CorAth), Atrio-ventricular conduction disorders (AVCD), Cardiac arrhythmias (Arrhyt), Atrial Fibrillation (AtrFib), Pulmonary heart disease (PulHD), Sudden cardiac death (SuddCD), Hypotension (Hypotension), Cardiovascular disease (CVD), Influenza and pneumonia (Flu-Pneu), Respiratory infections (InfResp), Asthma (Asthma), COPD and chronic bronchitis (COPD), Chronic lower respiratory diseases (COPD + Asthma) (CLRD), Respiratory disease (RD), Cardio-respiratory disease (Cardio-Resp), Kidney stone (KidStone), Acute renal failure (AcuteRen), Renal/genitourinary disease (GUM), Gastroenteritis (Gastro), Intestinal infection (IntInf), Infectious disease (meningitis + other inflamatory diseases) (ID), Diabetes mellitus (Diab), Endocrine diseases (Endocr), Organic mental disorders (Demen), Psychoactive substance use (Psyco), Schizophrenia (Schizo), Mental diseases (Mental), Extra-pyramidal disorders (Park), Other disorders of the nervous system (DegDis), Nervous system diseases (Nervous), Digestive system diseases (Dig), Dehydration (Dehyd), Heatstroke (HStroke), Heat related disease (Heat). 13 publications are only part of the systematic review and not the meta-analysis: IDs 4,11,23,27,29,34 apply DTR as the exposure. ID 36 presents a non-linear risk at a threshold temperature, which is not comparable to per 1 °C change in temperature. IDs 56--61 present a risk estimate as a comparison of two temperatures, also not comparable to per 1 °C change in temperature.

  Author, year         ID   Location                          Time-series   Heat and/or cold effect   Exposure                 Mortality or morbidity   Disease outcome and elderly age                                                                                                                                                     Additional information
  -------------------- ---- --------------------------------- ------------- ------------------------- ------------------------ ------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------
  Harlan, 2014         1    Arizona, USA                      2000--2008    Heat                      Max ADT                  Mortality                Heat, CVD, COPD/Asthma (65 +)                                                                                                                                                       Clarified this is not a heatwave paper, sample size
  Burkart, 2014        2    26 regions, Bangladesh            2003--2007    Heat                      UTCI                     Mortality                CVD, ID (65 +)                                                                                                                                                                      RR, 95% CI
  Huang, 2014          3    Changsha, China                   2008--2011    Heat                      MDT                      Mortality                CVD (65 +)                                                                                                                                                                          No
  Yang, 2013           4    Guangzhou, China                  2003--2010    Heat and cold             DTR                      Mortality                CVD, RD (65 +)                                                                                                                                                                      Sample size, threshold t
  Almeida, 2013        5    Lisbon and Oporto, Portugal       2000--2004    Heat                      Max ADT                  Mortality                CVD, RD (65 +)                                                                                                                                                                      No
  Gasparrini, 2012     6    England and Wales                 1993--2006    Heat                      Max DT                   Mortality                CBD, IHD, MI, ChIHD, PulHD, AVCD, AtrFib, Arrhyt, HeartFail, CVD, InfResp, COPD, PulHD, Asthma, RD, Diab, Endocr, Demen, Schizo, Mental, Park, DegDis, Nervous, GUM, Renal (65 +)   No
  Liu, 2011            7    Beijing, China                    2003--2005    Heat and cold             2-day or 15-day Mean T   Mortality                CBD, IHD, CVD, RD, Cardio-Resp (65 +)                                                                                                                                               No
  Wichmann, 2011       8    Copenhagen, Denmark               1999--2006    Heat and cold             Max ADT                  Mortality                CVD, CBD, RD (66 +)                                                                                                                                                                 No
  Yu, 2011             9    Brisbane, Australia               1996--2004    Heat and cold             MDT                      Mortality                CVD (65 +)                                                                                                                                                                          No
  Almeida, 2010        10   Lisbon and Oporto, Portugal       2000--2004    Heat                      Mean ADT                 Mortality                CVD, RD (65 +)                                                                                                                                                                      No
  Tam, 2009            11   Hong Kong                         1997--2002    Heat                      DTR                      Mortality                CVD (65 +)                                                                                                                                                                          No
  Revich, 2008         12   Moscow, Russia                    2000--2005    Heat and cold             MDT                      Mortality                IHD, CBD, CLRD (75 +)                                                                                                                                                               No
  Baccini, 2008        13   15 European cities                1990--2000    Heat                      Max ADT                  Mortality                CVD, RD (65 +)                                                                                                                                                                      B-estimate, se, sample size, threshold t
  Ishigami, 2008       14   Budapest, London and Milan        1993--2004    Heat                      MDT                      Mortality                CVD, RD (75 +)                                                                                                                                                                      No
  Gouveia, 2003        15   Sao Paulo, Brazil                 1991--1994    Heat and cold             MDT                      Mortality                CVD, RD (65 +)                                                                                                                                                                      Sample size
  Wong, 2014           16   Hong Kong                         2001--2005    Cold                      MDT                      Mortality                RD in patients with existing hypertension (65 +)                                                                                                                                    Lag, threshold t
  Xu, 2013             17   Hong Kong                         1998--2001    Cold                      Mean ADT                 Mortality                CVD, RD (65 +)                                                                                                                                                                      No
  Analitis, 2008       18   15 European cities                1990--2000    Cold                      Min ADT                  Mortality                CVD, CBD, RD (65 +)                                                                                                                                                                 RR, CI, sample size
  Carder, 2005         19   3 regions, Scotland               1981--2001    Cold                      MDT                      Mortality                CVD, RD (65 +)                                                                                                                                                                      Sample size
  Cagle, 2005          20   Washington, USA                   1980--2001    Cold                      MDT                      Mortality                CVD (55 +)                                                                                                                                                                          No
  Condemi, 2015        21   Cuneo, Italy                      2007--2010    Heat                      MDT                      Morbidity                KidStone (65 +)                                                                                                                                                                     No
  Han, 2015            22   Seoul, South Korea                2004--2013    Heat                      Monthly MDT              Morbidity                CBD, IS, IntH (60 +)                                                                                                                                                                No
  Li, 2014             23   Ghangzhou, China                  2010--2012    Heat                      DTR                      Morbidity                InfResp (65 +)                                                                                                                                                                      No
  Kim 2014             24   Seoul, South Korea                2007--2010    Heat and cold             MDT                      Morbidity                Asthma (65 +)                                                                                                                                                                       No
  Giang, 2014          25   Thai Nguyen, Vietnam              2008--2012    Heat and cold             MDT                      Morbidity                CVD (60 +)                                                                                                                                                                          No
  Anderson, 2013       26   213 USA counties                  1999--2008    Heat                      MDT                      Morbidity                COPD, RD (65 +)                                                                                                                                                                     No
  Wang, 2013           27   Beijing, China                    2009--2011    Heat                      DTR                      Morbidity                CVD, RD, Renal, Dig (65 +)                                                                                                                                                          No
  Chan, 2013           28   Hong Kong                         1998--2009    Heat and cold             MDT                      Morbidity                RD, ID (60 +)                                                                                                                                                                       Sample size
  Qiu, 2013            29   Hong Kong                         2000--2007    Heat                      DTR                      Morbidity                HF (65 +)                                                                                                                                                                           No
  Wichmann, 2013       30   Gothenburg, Sweden                1985--2010    Heat                      Max ADT                  Morbidity                AMI (66 +)                                                                                                                                                                          No
  Williams, 2012       31   Adelaide, Australia               2003--2009    Heat                      Min DT                   Morbidity                Renal, heat (65 +)                                                                                                                                                                  No
  Goggins, 2012        32   Hong Kong                         1999--2006    Heat and cold             MDT                      Morbidity                IS (65 +)                                                                                                                                                                           Sample size
  Wichmann, 2012       33   Copenhagen, Denmark               1999--2006    Heat and cold             Max ADT                  Morbidity                AMI (66 +)                                                                                                                                                                          No
  Lim, 2012            34   4 cities, South Korea             2003--2006    Heat                      DTR                      Morbidity                Asthma (75 +)                                                                                                                                                                       No
  Basu 2012            35   California, USA                   2005--2008    Heat                      Mean ADT                 Morbidity                CVD, Arrhyt, Aneurysm, IHD, Hypertension, HS, IS, Hypotension, RD, AcuteRen, Hstroke, IntInf, Diab, Dehyd (65 +)                                                                    RR, CI, sample size
  Vida, 2012           36   3 regions in Quebec, Canada       1995--2007    Heat                      MDT                      Morbidity                Mental (65 +)                                                                                                                                                                       Clarified effect is not per 1 °C increase in temperature
  Silva, 2012          37   Sao Paulo, Brazil                 2003--2007    Heat and cold             Max DT                   Morbidity                CVD, RD (60 +)                                                                                                                                                                      RR, CI
  Alessandrini, 2011   38   9 regions Emilia-Romagna, Italy   2002--2006    Heat and cold             Mean ADT                 Morbidity                CVD, RD (65 +)                                                                                                                                                                      No
  Pudpong, 2011        39   Chang Mai, Thailand               2002--2006    Heat                      MDT                      Morbidity                RD, CVD, Diab, IntInf (65 +)                                                                                                                                                        Sample size
  Morabito, 2011       40   Tuscany, Italy                    1997--2006    Heat and cold             MDT                      Morbidity                SAH, IntH, IS, Stroke (65 +)                                                                                                                                                        No
  Hopstock, 2011       41   Tromso, Norway                    1974--2004    Heat                      3-day Mean T             Morbidity                MI (65 +)                                                                                                                                                                           Sample size
  Wichmann, 2011       42   Copenhagen, Denmark               2002--2006    Heat and cold             Max ADT                  Morbidity                RD, CVD, CBD (66 +)                                                                                                                                                                 No
  Green, 2010          43   California, USA                   1999--2005    Heat                      Mean ADT                 Morbidity                Flu-Pneu, IS, Dehyd, Gastro, Diab, AcuteRen (65 +)                                                                                                                                  RR, CI, sample size
  Lin, 2009            44   New York, USA                     1991--2004    Heat                      Mean ADT                 Morbidity                CVD, RD (50 +)                                                                                                                                                                      CI, sample size
  Michelozzi, 2009     45   12 European cities                1990--2001    Heat                      Max ADT                  Morbidity                CVD, CBD, RD (65 +)                                                                                                                                                                 No
  Linares, 2008        46   Madrid, Spain                     1995--2000    Heat                      Max DT                   Morbidity                RD (75 +)                                                                                                                                                                           No
  Kovats, 2004         47   London, UK                        1994--2000    Heat                      MDT                      Morbidity                RD (65 +)                                                                                                                                                                           Sample size
  Koken, 2003          48   Denver, USA                       19,931,997    Heat                      Max DT                   Morbidity                AMI, CorAth, PulHD, Arrhyt, HF (65 +)                                                                                                                                               No
  Liu, 2014            49   Shanghai, China                   2008--2011    Cold                      MDT                      Morbidity                Flu-Pneu (65 +)                                                                                                                                                                     No
  Vasconcelos, 2013    50   Lisbon and Opoto, Portugal        2003--2007    Cold                      PET index                Morbidity                CVD, AMI (65 +)                                                                                                                                                                     No
  Bhaskaran, 2010      51   England and Wales                 2003--2006    Cold                      MDT                      Morbidity                MI (65 +)                                                                                                                                                                           Sample size
  Ebi, 2004            52   3 cities, California, USA         1983--1998    Cold                      Max DT                   Morbidity                CBD, AMI, Angina, HF (55 +)                                                                                                                                                         No
  Hong 2003            53   Incheon, Korea                    1998 2000     Cold                      MDT                      Morbidity                IS (65 +)                                                                                                                                                                           No
  Hajat, 2002          54   London, UK                        1992--1995    Cold                      MDT                      Morbidity                RD, Asthma, Lower RD, Upper RD, CVD (65 +)                                                                                                                                          No
  Ebi, 2001            55   3 cities, California, USA         1983--1998    Cold                      Min DT                   Morbidity                Flu-Pneu (56 +)                                                                                                                                                                     No
  Breitner, 2014       56   Bavaria, Germany                  1990--2006    Heat and cold             MDT                      Mortality                CVD (75 +)                                                                                                                                                                          No
  Tian, 2012           57   Beijing, China                    2000--2011    Heat and cold             MDT                      Mortality                Coronary heart disease (65 +)                                                                                                                                                       No
  Lin, 2011            58   4 regions, Taiwan                 1994--2007    Heat and cold             MDT                      Mortality                CVD, RD (65 +)                                                                                                                                                                      No
  O′Neill 2003         59   7 counties, Chicago, USA          1986--1993    Heat and cold             Mean ADT                 Mortality                RD, CVD (65 +)                                                                                                                                                                      No
  Pan, 1995            60   Taiwan                            1981--1991    Heat and cold             MDT                      Mortality                IS, IHD, HS (64 +)                                                                                                                                                                  No
  Son, 2014            61   8 cities, South Korea             2003--2008    Heat and cold             MDT                      Morbidity                Allergy, Asthma, RD, CVD (65 +)                                                                                                                                                     No

###### 

Random-effects meta-analytic % change (and 95% confidence interval) for heat and cold related cerebrovascular, cardiovascular and respiratory mortality.

Heat outcomes correspond to percentage change per 1 °C increase in temperature above a heat threshold in summer months, across the year or as a linear risk. Cold outcomes correspond to percentage change per 1 °C decrease in temperature below a threshold in winter months, across the year or as a linear risk. Meta-analysis is conducted when k (number of city-specific risk estimates) \> 2. \* indicates a statistically significant percentage change at the 5% level, arrow direction = risk increase or decrease. I^2^ = heterogeneity score, p = p-value for the heterogeneity score.

Sample size was not obtainable for the following studies: Revich 2008 ^a^, Ishigami 2008 ^b^, Harlan 2014 ^c^, Wong 2014 ^d^.

  ICD-10 code                                                             Cause of death (k \> 2)       Mortality heat        Mortality cold                                                                                             
  ----------------------------------------------------------------------- ----------------------------- --------------------- ---------------- ---------------------------------------------------------------- -------------------- --- ----------------------------------------------------------
  *Cerebrovascular*                                                                                                                                                                                                                      
  I60--I69                                                                All cerebrovascular disease   1.40(0.06--2.75)\*    ↑                k = 3, I^2^ = 70.2%, p = 0.0349, n = 224,026                     1.21(0.66--1.77)\*   ↑   k = 14, I^2^ = 60.8%, p = 0.0016, n = 95,935
  I60--I69 I61--I62, I64                                                  Overall                       1.40(0.06--2.75)\*    ↑                k = 3, I^2^ = 70.2%, p = 0.0349, n = 224,026                     1.21(0.66--1.77)\*   ↑   k = 14, I^2^ = 60.8%, p = \< 0.0001, n = 95,935
                                                                                                                                                                                                                                         
  *Cardiovascular*                                                                                                                                                                                                                       
  I20--I25                                                                Ischemic heart disease        1.62(0.24--3.03)\*    ↑                k = 3, I^2^ = 81.5%, p = 0.0045, n = 411220^a^                   0.45(− 0.01--0.91)   ↑   k = 2, I^2^ = 99.2%, p = \< 0.0001, n = 6356 ^a^
  I00--I99                                                                All cardiovascular disease    3.79(3.40--4.18\]\*   ↑                k = 31, I^2^ = 99.3%, p = \< 0.0001, n = 1,319,818 ^a,\ b,\ c^   1.84(0.85--2.84)\*   ↑   k = 24, I^2^ = 98.6%, p = \< 0.0001, n = 688,206 ^a^
  I21--23, I20, I50, I00--I99, I20--I25, I27.9, I70, I26--I28, I44, I45   Overall                       3.44(3.1--3.78)\*     ↑                k = 41, I^2^ = 99%, p = \< 0.0001, n = 2,147,349 ^a,\ b,\ c^     1.66(1.19--2.14)\*   ↑   k = 26, I^2^ = 98.9%, p = \< 0.0001, n = 694562^a^
                                                                                                                                                                                                                                         
  *Respiratory*                                                                                                                                                                                                                          
  J00--J99                                                                All respiratory disease       2.32(2.02--2.62)\*    ↑                k = 26, I^2^ = 92.8%, p = \< 0.0001, n = 367,468                 2.90(1.84--3.97)\*   ↑   k = 22, I^2^ = 90.5%, p = \< 0.0001, n = 168,198 ^a,\ d^
  J09--J19, J40--44, J45--J46, J00--J99                                   Overall                       3.60(3.18--4.02)\*    ↑                k = 31, I^2^ = 97.5%, p = \< 0.0001, n = 599,458 ^c^             2.90(1.84--3.97)\*   ↑   k = 22, I^2^ = 90.5%, p = \< 0.0001, n = 168,198 ^a,\ d^

###### 

Random-effects meta-analytic % change (and 95% confidence interval) for heat and cold related cerebrovascular, cardiovascular, respiratory, endocrine, genitourinary, infectious and heat-related morbidity outcomes.

Heat outcomes correspond to percentage change per 1 °C increase in temperature above a heat threshold in summer months, across the year or as a linear risk. Cold outcomes correspond to percentage change per 1 °C decrease in temperature below a threshold in winter months, across the year or as a linear risk. Meta-analysis is conducted when k (number of city-specific risk estimates) \> 2. \* indicates a statistically significant RR at the 5% level, arrows indicate risk increase or decrease, -- indicates no change in risk. I^2^ = heterogeneity score. Sample size was not obtainable for the following studies: Hajat 2002 ^a^, Vasconcelos 2013 ^b^, Alessandrini 2011 ^c^, Michelozzi 2009 (65--74 year age group) ^d^, Hopstock 2011 ^e^, Alessandrini 2011 ^f^, Williams 2012 ^g^.

  ICD-10 code                                         Cause of morbidity (k \> 2)   Morbidity heat         Morbidity cold                                                                                                
  --------------------------------------------------- ----------------------------- ---------------------- ---------------- ---------------------------------------------------------------- ---------------------- ---- ----------------------------------------------------------------
  *Cerebrovascular*                                                                                                                                                                                                      
  I63                                                 Ischemic stroke               0.33(− 0.09--0.75)     ↑                k = 5, I^2^ = 84.9%, p = \< 0.0001, n = 178,487                  3.63(− 3.94--11.8)     ↑    k = 2, I^2^ = 85.8%, p = 0.008, n = 39,658
  I61                                                 Intracerebral haemorrhage     − 0.66(− 2.13--0.84)   ↓                k = 2, I^2^ = 88.6%, p = 0.0031, n = 10,739                      1.49(1.04--1.94)\*     ↑    k = 2, I^2^ = 0%, p = 0.3908, n = 92,991
  I20--I25                                            All cerebrovascular           − 0.17(− 0.96--0.63)   ↓                k = 4, I^2^ = 46.6%,0.1318, n = 212,616 ^d^                      − 0.46(− 1.12--0.2)    ↓    k = 8, I^2^ = 98.6%, p = \< 0.0001, n = 552,527
  I60, I61, I63, I20--I25                             Overall                       0.08(− 0.01--0.17)     ↑                k = 12 I^2^ = 76.9%, p = \< 0.0001, n = 347,098 ^d^              0.05(− 0.37--0.47)     ↑    k = 14, I^2^ = 97.9%, p = \< 0.0001, n = 733,743
                                                                                                                                                                                                                         
  *Cardiovascular*                                                                                                                                                                                                       
  I21--I23                                            Myocardial infarction         − 0.16(− 2.05--1.77)   ↓                k = 3, I^2^ = 73.4%, p = \< 0.0001, n = 5842 ^e^                 0.66(− 0.14--1.48)     ↑    k = 7, I^2^ = 93%, p = \< 0.0001, n = 339,073 ^b^
  I20                                                 Angina pectoris               NA                                      NA                                                               − 0.80(− 2.21--0.64)   ↓    k = 3, I^2^ = 90.1%, p = \< 0.0001, n = 331,324
  I50                                                 Heart failure                 NA                                      NA                                                               − 0.67(− 2.15--0.83)   ↓    k = 3, I^2^ = 96.4%, p = \< 0.0001, n = 457,437
  I00--I99                                            All cardiovascular disease    0.30(− 0.12--0.81)     ↑                k = 9, I^2^ = 93.5%, p = \< 0.0001, n = 929,168 ^d,\ f^          − 0.28(− 1.39--0.84)   ↓    k = 6, I^2^ = 57.3%, p = \< 0.0388, n = 4,371,849 ^a,\ c^
  I21--23, I20, I50, I00--I99, I20--I25, I27.9, I70   Overall                       0.15(− 0.05--0.35)     ↑                k = 20, I^2^ = 97.6%, p = \< 0.0001, n = 1,015,480 ^d,\ e,\ f^   0.00(− 0.67--0.66)     --   k = 19, I^2^ = 96.6%, p = \< 0.0001, n = 5,499,683 ^a,\ b,\ c^
                                                                                                                                                                                                                         
  *Respiratory*                                                                                                                                                                                                          
  J45--J46                                            Asthma                        NA                                      NA                                                               3.84(− 9.38--18.99)    ↑    k = 2, I^2^ = 81.2%, p = 0.0212, n = 3885 ^a,\ c^
  J09--J18                                            Pneumonia                     NA                                      NA                                                               6.89(1.20--12.99)\*    ↑    k = 4, I^2^ = 94.5%, p = \< 0.0001, n = 68,968
  J00--J99                                            All respiratory disease       2.76(1.51--4.03)\*     ↑                k = 20, I^2^ = 82.5%, p = \< 0.0001, n = 121,078                 2.70(− 0.72--6.24)     ↑    k = 5, I^2^ = 91.9%, p = \< 0.0001, n = 1,267,454 ^f^
  J00--J99, J40--J44, J09--J18, J45--46               Overall                       1.65(1.09--2.21)\*     ↑                k = 23, I^2^ = 81.4%, p = \< 0.0001, n = 2,530,203               4.93(1.54--8.44)\*     ↑    k = 13, I^2^ = 97.1%, p = \< 0.0001, n = 1,808,820 ^a,\ c,\ f^
                                                                                                                                                                                                                         
  *Endocrine*                                                                                                                                                                                                            
  E10--E14                                            Diabetes mellitus             1.02(0.43--1.62)\*     ↑                k = 3, I^2^ = 25.3%, p = 0.2623, n = 18,393                      NA                          NA
                                                                                                                                                                                                                         
  *Genitourinary*                                                                                                                                                                                                        
  N17                                                 Acute renal failure           2.12(1.59--2.65)\*     ↑                k = 2, I^2^ = 16%, p = 0.2752, n = 26,359                        NA                          NA
  E10--E14                                            Overall                       2.12(1.65--2.59)\*     ↑                k = 4, I^2^ = 0%, p = 0.4613, n = 26,798 ^g^                                                 
                                                                                                                                                                                                                         
  *Infectious*                                                                                                                                                                                                           
  A00--99                                             Intestinal infectious         1.00(− 0.21--2.22)     ↑                k = 2, I^2^ = 0%, p = 0.05228, n = 6064                          NA                          NA
  A00--B99, G00--G05, N70--74, N76                    Overall                       0.76(− 0.43--1.95)     ↑                k = 4, I^2^ = 27.2%, p = 0.2487, n = 148,663                     NA                          NA
                                                                                                                                                                                                                         
  *Heat*                                                                                                                                                                                                                 
  E86                                                 Dehydration                   3.12(0.74--5.56)\*     ↑                k = 2, I^2^ = 77.7%, p = \< 0.0001, n = 28,901                   NA                          NA
  E86, T67, E70--90, X30                              Overall                       14.83(8.22--21.84)\*   ↑                k = 2, I^2^ = 98.3%, p = \< 0.0001, n = 29,753 ^g^               NA                          NA
